Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients. (12th May 2021) - Tolaney, Sara M.; Ziehr, David R.; Guo, Hao; Ng, Mei R.; Barry, William T.; Higgins, Michaela J.; Isakoff, Steven J.; Brock, Jane E.; Ivanova, Elena V.; Paweletz, Cloud P.; Demeo, Michelle K.; Ramaiya, Nikhil H.; et al.